Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS (NCT07266376)
Validation of a VOICE MAnagement Program in Schizophrenia
🩺 Plain-English Summary (8th-Grade Level)
Approximately 25-50% of patients with schizophrenia experience treatment-resistant Auditory Verbal Hallucinations (AVHs), which contribute to the development of associated psychopathological disorders (e.g., anxiety, depression, suicidal ideation). Various validated psychotherapeutic strategies and tools for managing treatment-resistant AVHs have been combined into an integrative therapeutic program. The main objective of this study is to evaluate the efficacy of this program in reducing the frequency and intensity of AVHs, as well as its impact on comorbid psychopathology (e.g., depression, anxiety, self-esteem, substance use) in patients with schizophrenia or schizoaffective disorder who experience treatment-resistant AVHs.
Who can join: Review the eligibility criteria below.
Location: Public Mental Health Institution of Guadeloupe — Les Abymes
Age range: 18 Years
🧪 Interventions in This Study
- Integrative group therapy (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Public Mental Health Institution of Guadeloupe — Les Abymes,
📞 Contact the Study Coordinator
Phone: +590590934667
Email: melanie.petapermal@chu-guadeloupe.fr
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Mental Disorder
- Enhancing Immune Health Randomized Controlled Trial — Chicago, Illinois
- CapExchange: A Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery — Saint-Claude,
- Pharmacogenomics-Supported Psychotropic Prescribing Trial — Winnipeg, Manitoba
- Healthy ReStart Intervention to Improve Health and Functioning — Chicago, Illinois
Explore by condition: All Mental Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.